Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Florkowski

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Clinical Biochemistry|December 28, 2011
β37Trp→Cys mutation leads to multiple new hemoglobin species in red cellsStephen O Brennan, Richard I King, Christopher M Florkowski
Clinical Chemistry|January 20, 2012
A right Royal porphyria fallacyChristiaan W Sies, Christopher M Florkowski, Linda S Pike
Diabetes Research and Clinical Practice|January 24, 2004
Death Certification and New Zealand Health Information Service (NZHIS) statistics for diabetes mellitus: an under-recognised health problemFrank Chen, Christopher M Florkowski, Marion Dever, et al.
Clinical Chemistry and Laboratory Medicine|November 9, 2017
Impact of citrated blood collection tubes on red cell morphology: implications for the measurement of plasma glucoseHelen Lunt, Helen F Heenan, Peter Edwards, et al.
Diabetes Research and Clinical Practice|March 11, 2008
Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-upShelagh I Dawson, Jinny Willis, Christopher M Florkowski, et al.
Clinical Chemistry|February 1, 2005
Biological variation of coenzyme Q10Sarah L Molyneux, Christopher M Florkowski, Michael Lever, et al.
Annals of Clinical Biochemistry|January 5, 2006
Dual porphyria with mutations in both the UROD and HMBS genesJames R Harraway, Christopher M Florkowski, Christiaan Sies, et al.
The Medical Journal of Australia|January 10, 2006
Chronic kidney disease and automatic reporting of estimated glomerular filtration rateChristopher M Florkowski, Wolf W Woltersdorf, Peter M George, et al.
Circulation|November 26, 2014
Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"Paul K L Chin, Daniel F B Wright, Christopher M Florkowski
Diabetes Research and Clinical Practice|March 11, 2008
All-cause mortality in insulin-treated diabetic patients: a 20-year follow-upShelagh I Dawson, Jinny Willis, Christopher M Florkowski, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Clinical Biochemistry|December 28, 2011
β37Trp→Cys mutation leads to multiple new hemoglobin species in red cellsStephen O Brennan, Richard I King, Christopher M Florkowski
Clinical Chemistry|January 20, 2012
A right Royal porphyria fallacyChristiaan W Sies, Christopher M Florkowski, Linda S Pike
Diabetes Research and Clinical Practice|January 24, 2004
Death Certification and New Zealand Health Information Service (NZHIS) statistics for diabetes mellitus: an under-recognised health problemFrank Chen, Christopher M Florkowski, Marion Dever, et al.
Clinical Chemistry and Laboratory Medicine|November 9, 2017
Impact of citrated blood collection tubes on red cell morphology: implications for the measurement of plasma glucoseHelen Lunt, Helen F Heenan, Peter Edwards, et al.
Diabetes Research and Clinical Practice|March 11, 2008
Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-upShelagh I Dawson, Jinny Willis, Christopher M Florkowski, et al.
Clinical Chemistry|February 1, 2005
Biological variation of coenzyme Q10Sarah L Molyneux, Christopher M Florkowski, Michael Lever, et al.
Annals of Clinical Biochemistry|January 5, 2006
Dual porphyria with mutations in both the UROD and HMBS genesJames R Harraway, Christopher M Florkowski, Christiaan Sies, et al.
The Medical Journal of Australia|January 10, 2006
Chronic kidney disease and automatic reporting of estimated glomerular filtration rateChristopher M Florkowski, Wolf W Woltersdorf, Peter M George, et al.
Circulation|November 26, 2014
Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"Paul K L Chin, Daniel F B Wright, Christopher M Florkowski
Diabetes Research and Clinical Practice|March 11, 2008
All-cause mortality in insulin-treated diabetic patients: a 20-year follow-upShelagh I Dawson, Jinny Willis, Christopher M Florkowski, et al.
Pageof 8